• Berbamine hydrochloride: Reliable NF-κB Inhibitor for Cancer

  2026-06-09

  This article explores how Berbamine hydrochloride (SKU N2471) offers reproducible, literature-backed solutions to common challenges in cell viability and cancer signaling assays. With a focus on workflow integration, validated IC50 values, and vendor reliability, researchers gain evidence-based guidance for using this potent NF-κB activity inhibitor in advanced oncology experiments.

• Tetraethylammonium Chloride: Precision in K+ Channel Blockad

  2026-06-09

  Tetraethylammonium chloride (TEAC) from APExBIO offers unmatched experimental control for vascular, neuronal, and metabolic K+ channel assays. Integrating landmark mechanistic insights, this guide delivers actionable protocols, troubleshooting strategies, and advanced applications for robust, reproducible research outcomes.

• Catalpol and Osteoclast Apoptosis: A New Paradigm in Osteopo

  2026-06-08

  Explore how Catalpol, a natural iridoid glycoside, pioneers bone disease research by promoting osteoclast apoptosis via the Sirt6-ERα-FasL axis. This article uniquely focuses on Catalpol’s mechanistic depth and translational value in osteoporosis animal models.

• Spiroplasma eriocheiris Entry via Clathrin-Dependent Pathway

  2026-06-08

  This study provides the first direct evidence that Spiroplasma eriocheiris invades Drosophila Schneider 2 cells through clathrin-mediated endocytosis and macropinocytosis. The work establishes a robust invertebrate model for dissecting pathogen entry and highlights the value of pathway-specific inhibitors in infection biology.

• Non-Canonical Dlat-Trpv3 Pathway Drives Adipose Thermogenesi

  2026-06-07

  This study introduces a novel mechanism for promoting adipose thermogenesis via the Dlat-Trpv3-Ca2+-AMPK axis, using hyperforin as a non-canonical activator with favorable safety and pharmacokinetics. The research demonstrates that bypassing the β3-adrenergic pathway overcomes key limitations in anti-obesity therapy, offering mechanistic insights and a foundation for translational metabolic research.

• Central Neural Pathways in Opioid-Induced Mechanical Hyperse

  2026-06-06

  Yin et al. (2024) reveal a brain-to-spinal neural circuit controlling opioid-induced mechanical hypersensitivity and morphine tolerance. Their findings provide mechanistic insight into central opioid signaling and suggest new targets for mitigating adverse effects in chronic pain models.

• Applied Angiotensin II Workflows: Hypertrophy & Fibrosis Mod

  2026-06-05

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) from APExBIO empowers advanced vascular research with high solubility, rigorous batch quality, and workflow-proven reproducibility. This guide details setup, optimization, and troubleshooting for hypertension, vascular remodeling, and renal fibrosis studies, integrating insights from recent mechanistic breakthroughs.

• Angiotensin 1/2 (2-7): Peptide Fragment for RAS Research

  2026-06-05

  Angiotensin 1/2 (2-7) is a biologically active peptide fragment central to blood pressure regulation research. It acts as a potent vasoconstrictor and modulates key events in the renin-angiotensin system, with validated roles in both cardiovascular and viral pathogenesis studies.

• DOT1L Inhibition Enhances Lenalidomide Response in Myeloma

  2026-06-04

  The reference study demonstrates that targeting the histone methyltransferase DOT1L in multiple myeloma cells reprograms innate immunity, leading to reinforced interferon signaling and improved efficacy of immunomodulatory drugs like lenalidomide. These findings provide mechanistic insight into the synergy between epigenetic regulation and immune modulation, highlighting new avenues for therapeutic strategies in multiple myeloma.

• Protein A/G Magnetic Co-IP/IP Kit: Precision in Protein Inte

  2026-06-04

  The Protein A/G Magnetic Co-IP/IP Kit leverages recombinant Protein A/G magnetic beads for high-yield, low-background isolation of protein complexes, accelerating co-immunoprecipitation and antibody purification workflows. Its optimized protocol and robust components deliver reproducible results for protein-protein interaction studies, even from limited or challenging biological samples.

• Ordered DNA Nanostructures Enhance Enzymatic DNA Synthesis

  2026-06-03

  This study demonstrates that highly ordered tetrahedral DNA nanostructures (TDNs) can dramatically improve enzymatic oligonucleotide synthesis (EOS), overcoming key limitations of primer accessibility and spatial hindrance. The findings open new avenues for accurate, high-yield DNA synthesis, especially in applications such as DNA data storage.

• Cefazedone (Refosporen): Applied Protocols for Antibacterial

  2026-06-03

  Cefazedone (Refosporen) stands out as a β-lactamase-resistant, first-generation cephalosporin with robust efficacy for both Gram-positive and Gram-negative bacterial infections. This guide delivers actionable experimental workflows, troubleshooting insights, and data-backed protocol enhancements for maximizing Cefazedone’s translational research value.

• Angiotensin 1/2 (2-7): Bridging Cardiovascular and Viral Res

  2026-06-02

  Explore how Angiotensin 1/2 (2-7) is reshaping translational research across cardiovascular and infectious disease domains. This article delivers mechanistic insights, protocol guidance, and critical analysis of emerging evidence—positioning APExBIO’s high-purity peptide as a cornerstone for next-generation studies in blood pressure regulation and viral-host interaction.

• A-1331852: Advanced BCL-XL Inhibitor Workflows for Cancer Re

  2026-06-02

  A-1331852 stands out as a highly selective BCL-XL inhibitor, enabling precise apoptosis induction in cancer models with robust potency and workflow flexibility. This article details state-of-the-art protocols, troubleshooting insights, and real-world applications, drawing on recent breakthroughs in targeting BCL-2 family protein inhibition—especially for resistant and stem-like tumor subpopulations.

• Angiotensin II and Vascular Senescence: Mechanisms and Pathw

  2026-06-01

  This thought-leadership article synthesizes the latest mechanistic insights on Angiotensin II—especially its role in endothelial dysfunction and vascular aging—with practical guidance for translational researchers. Drawing on recent evidence, including the regulatory role of mitofusin 2 in Ang II-induced endothelial senescence, the article charts a strategic path for advancing vascular smooth muscle cell hypertrophy and hypertension mechanism studies. It also positions APExBIO’s Angiotensin II as a validated, reproducible research tool, while contextualizing its use within evolving experimental and clinical frameworks.

16222 records 1/1082 page Next 12345 下5页 Last page